Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 1/20 | 0.50 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.45 |
| ▸ | G6PD | P11413 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.44 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3692997 | 0.96 | ERN1 (0.50) | ERN1PTPN22POLBHKDC1G6PD | |
| SCHEMBL2761906 | 0.96 | ERN1 (0.50) | ERN1PTPN22POLBHKDC1G6PD | |
| SCHEMBL11046405 | 0.82 | ERN1 (0.55) | ERN1PTPN22POLBHKDC1G6PD | |
| SCHEMBL29625740 | 0.82 | ERN1 (0.55) | ERN1PTPN22POLBHKDC1G6PD | |
| SCHEMBL564094 | 0.81 | ERN1 (0.53) | ERN1PTPN22POLBHKDC1G6PD | |
| SCHEMBL3035364 | 0.81 | ERN1 (0.53) | ERN1PTPN22POLBHKDC1G6PD | |
| SCHEMBL7203177 | 0.79 | ERN1 (0.52) | ERN1PTPN22POLBHKDC1G6PD | |
| SCHEMBL1730362 | 0.79 | ERN1 (0.52) | ERN1PTPN22POLBHKDC1G6PD | |
| SCHEMBL20885914 | 0.79 | ERN1 (0.52) | ERN1PTPN22POLBHKDC1G6PD | |
| SCHEMBL3233249 | 0.79 | CA1 (0.41) | ERN1HSD17B10ALDH1A1HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1584 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-214916020-U | Alkali fusion device for producing 2-naphthol and 2-naphthol production system | 内蒙古美力坚科技化工有限公司 | 2021-11-30 | — | — | CN | claimed |
| CN-106459939-B | Lipase variants and polynucleotides encoding same | 诺维信公司 | 2026-05-22 | — | — | CN | disclosed |
| US-12630812-B2 | Subtilase variants and polynucleotides encoding same | NOVOZYMES A/S (DK) | 2026-05-19 | — | — | US | disclosed |
| US-20260132388-A1 | LIPASE VARIANTS AND MICROCAPSULE COMPOSITIONS COMPRISING SUCH LIPASE VARIANTS | NOVOZYMES A/S (DK) | 2026-05-14 | — | — | US | disclosed |
| EP-4739760-A1 | WASHING METHOD FOR REMOVING PROTEINACEOUS STAINS | Novozymes A/S (DK) | 2026-05-13 | — | — | EP | disclosed |
| CN-122029266-A | Use of xyloglucanases for replacing optical brighteners | 诺维信公司 | 2026-05-12 | — | — | CN | disclosed |
| EP-3607038-B1 | CLEANING COMPOSITIONS AND USES THEREOF | NOVOZYMES AS (DK) | 2026-05-06 | — | — | EP | disclosed |
| EP-4735563-A1 | DETERGENT COMPOSITION COMPRISING LIPASES | Novozymes A/S (DK) | 2026-05-06 | — | — | EP | disclosed |
| EP-3708660-B1 | POLYPEPTIDES | NOVOZYMES AS (DK) | 2026-04-29 | — | — | EP | disclosed |
| EP-4729596-A2 | DETERGENT COMPOSITION COMPRISING AMYLASE AND PROTEASE VARIANTS | Novozymes A/S (DK) | 2026-04-22 | — | — | EP | disclosed |
| US-7344236-B2 | Ink-jet cloth printing ink and an ink-jet recording method | KONICA-MINOLTA HOLDINGS, INC. (JP) | 2008-03-18 | — | — | US | disclosed |
| US-7341622-B2 | Ink-jet ink production method and ink-jet recording method | KONICA MINOLTA HOLDINGS, INC. (JP) | 2008-03-11 | — | — | US | disclosed |
| US-20050217536-A1 | Ink-jet ink production method and ink-jet recording method | KONICA MINOLTA HOLDINGS, INC. (JP) | 2005-10-06 | — | — | US | disclosed |
| US-20050057631-A1 | Ink-jet cloth printing ink and an ink-jet recording method | KONICA MINOLTA HOLDINGS, INC. (JP) | 2005-03-17 | — | — | US | disclosed |
| EP-1514969-A1 | An ink-jet cloth printing ink and an ink-jet recording method | KONICA MINOLTA HOLDINGS, INC. (JP) | 2005-03-16 | — | — | EP | disclosed |
| US-6733113-B2 | Ink-jet recording method and ink-jet recording apparatus | KONICA CORPORATION (JP) | 2004-05-11 | — | — | US | disclosed |
| US-20030043238-A1 | Ink-jet recording method and ink-jet recording apparatus | KONICA CORPORATION (JP) | 2003-03-06 | — | — | US | disclosed |
| EP-0718704-A1 | Electrophotographic toner and developer | MITA INDUSTRIAL CO. LTD. (JP) | 1996-06-26 | — | — | EP | disclosed |
| US-4390340-A | Tanning agent, its preparation and its use for retanning | BASF AKTIENGESELLSCHAFT (DE) | 1983-06-28 | — | — | US | disclosed |
| US-4120960-A | DIURETICS, SALURESIS | THE BOOTS COMPANY LIMITED (GB) | 1978-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132388-A1 | LIPASE VARIANTS AND MICROCAPSULE COMPOSITIONS COMPRISING SUCH LIPASE VARIANTS | LIPE, LPL, PNLIP | ERN1 1645/4885PTPN22 1563/4885POLB 1126/4885 |
| US-12630812-B2 | Subtilase variants and polynucleotides encoding same | RNASE1, PEPD, DPP9 | ERN1 431/4885PTPN22 927/4885POLB 550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.